Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Paraschos Archontakis Barakakis"'
Autor:
Paraschos Archontakis Barakakis, Leonidas Palaiodimos, Derlis Fleitas Sosa, Linda Benes, Perminder Gulani, Daniel Fein
Publikováno v:
Avicenna Journal of Medicine, Vol 09, Iss 04, Pp 134-142 (2019)
Background: The role of the combination of glucocorticosteroids and mineralocorticosteroids in treating septic shock is not well-defined. The aim of this study was to perform a systematic review and meta-analysis of the randomized controlled trials a
Externí odkaz:
https://doaj.org/article/34fc74c1c65343909533545c45c81e2d
Autor:
Artemis Mavridi, Aine Redmond, Paraschos Archontakis-Barakakis, Petya Bogdanova-Mihaylova, Christina I. Deligianni, Dimos D. Mitsikostas, Theodoros Mavridis
Publikováno v:
Toxins, Vol 16, Iss 7, p 295 (2024)
Migraine is a leading cause of disability worldwide, yet it remains underrecognized and undertreated, especially in the pediatric and adolescent population. Chronic migraine occurs approximately in 1% of children and adolescents requiring preventive
Externí odkaz:
https://doaj.org/article/b4f74b42e5b643c8ad319085ee9d3c2c
Autor:
Paraschos Archontakis Barakakis, Thuonghien Tran, Jee Young You, Gabriel J Hernandez Romero, Vipul Gidwani, Fernando J Martinez, Spyridon Fortis
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease. 18:469-482
Autor:
Sanjana Nagraj, Dimitrios Varrias, Amrin Kharawala, Sheetal V. Mathai, Jiyoung Seo, Hiba Narvel, Weijia Li, Damianos G. Kokkinidis, Paraschos Archontakis Barakakis, Andreas Tzoumas, Wasla Liaqat, Spyros Peppas, Leonidas Palaiodimos, Rosy Thachil
Publikováno v:
Cardiovascular Diagnosis and Therapy. 13:1-10
Autor:
Spyros Peppas, Sanjana Nagraj, George Koutsias, Michail Kladas, Paraschos Archontakis-Barakakis, Dimitrios Schizas, George Giannakoulas, Leonidas Palaiodimos, Damianos G. Kokkinidis
Publikováno v:
Heart, Lung and Circulation. 31:1191-1202
Portopulmonary hypertension is defined as the development of pulmonary arterial hypertension in the setting of portal hypertension with or without liver cirrhosis. Portal hypertension-associated haemodynamic changes, including hyperdynamic state, por
Autor:
Paraschos Archontakis Barakakis, Damianos G. Kokkinidis, Weijia Li, Sanjana Nagraj, Spyros Peppas, Michail Kladas, Dimitrios Schizas, Panagiotis Korantzopoulos, George Ntaios
Publikováno v:
Journal of Clinical Gastroenterology.
Autor:
Theodoros Mavridis, Nikolaos Papagiannakis, Marianthi Breza, Georgios D. Vavougios, Kostas Patas, Ariadne Daponte, Achilleas Laskaratos, Paraschos Archontakis-Barakakis, Ioannis Pantazopoulos, Dimos D. Mitsikostas
Publikováno v:
Journal of personalized medicine. 12(9)
Background: Multiple Sclerosis treatment with B-cell targeted therapies may be associated with an increased incidence of headache. We aimed to find and compare the association of B-cell targeted therapies with the incidence of headache in patients wi
Autor:
Paraschos Archontakis-Barakakis, Wei-Jia Li, Dimitrios Kalaitzoglou, Stefanos Giannopoulos, Leonidas Palaiodimos, Robert T. Faillace, Damianos G Kokkinidis, Yu-Chiang Wang, Lazaros Tzelves, Apostolos Manolopoulos
Publikováno v:
World Journal of Cardiology
Background Most of the randomized clinical trials that led to the wide use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation (AF) originated from western countries. Aim To systematically review
Autor:
Paraschos Archontakis‐Barakakis, Weijia Li, Dimitrios Kalaitzoglou, Lazaros Tzelves, Apostolos Manolopoulos, Stefanos Giannopoulos, Grigorios Giamouzis, George Giannakoulas, Apostolos Batsidis, Leonidas Palaiodimos, George Ntaios, Gregory Y. H. Lip, Damianos G. Kokkinidis
Publikováno v:
British journal of clinical pharmacologyREFERENCES. 88(11)
Observational studies have investigated the effectiveness and safety of direct oral anticoagulants (DOACs) and vitamin K antagonists (VKAs) used in nonvalvular atrial fibrillation. We performed a systematic review and meta-analysis assessing the risk
Autor:
Sanjana Nagraj, Weijia Li, Cristian Zamora, Paraschos Archontakis Barakakis, Damianos G Kokkinidis
Publikováno v:
Future cardiology. 18(3)
As the third most common cardiovascular disease, pulmonary embolism (PE) has an uptrending incidence and mortality, resulting in significant healthcare expenditure. Risk stratification of acute PE guides management. Although anticoagulation remains t